A new tool to find targets for pediatric brain tumor treatments

The TAPESTRY web application catalogs thousands of splicing events to help find new therapeutic targets.

Researchers built TAPESTRY, a database and web application. It helps people explore tumor-enriched splice junctions (TEJs) in pediatric brain tumors.

The tool catalogs 45,430 recurrent TEJs across 19 histologies. These were identified from 1,962 RNA-seq specimens, including 1,272 independent primary tumors.

A splice junction is a connection between parts of a gene. These junctions are compared to four normal brain reference cohorts. These cohorts include adult, pediatric, developmental, and cell-type-resolved tissue.

Each junction is classified as tumor-specific or oncofetal. Users can search by gene or splicing event and filter results by histology or junction class.

The tool supports the prioritization of splice-derived targets. These targets are for antibody-based, cell-based, and vaccine immunotherapies in pediatric brain and central nervous system tumors.

Key facts

  • TAPESTRY catalogs 45,430 recurrent tumor-enriched splice junctions.
  • The data includes 1,962 RNA-seq specimens from the Pediatric Brain Tumor Atlas.
  • The tool helps find targets for antibody-based, cell-based, and vaccine immunotherapies.

All sections

Edition